Pathfinder Wealth Consulting’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,828
Closed -$1.18M 77
2026
Q1
$1.18M Sell
4,828
-260
-5% -$60.6K 0.76% 34
2025
Q4
$1.05M Buy
+5,088
New +$1.01M 0.66% 37

Other funds holding JNJ

Pathfinder Wealth Consulting's JNJ Position: Q2 2026 in Review

Pathfinder Wealth Consulting sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 4,828 shares — an estimated $1.18M sold.

Pathfinder Wealth Consulting first reported a position in JNJ in Q4 2025 and held it in 2 quarters. The position peaked at $1.18M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Pathfinder Wealth Consulting reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Pathfinder Wealth Consulting sold 4,828 Johnson & Johnson shares in Q2 2026, an estimated $1.18M.
  • Pathfinder Wealth Consulting first reported a position in Johnson & Johnson in Q4 2025 and held it in 2 quarters.
  • Pathfinder Wealth Consulting's Johnson & Johnson position peaked at $1.18M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Pathfinder Wealth Consulting's 13F filing for Q2 2026.